NQO1 induction mediated by photodynamic therapy synergizes with β-Lapachone-halogenated derivative against melanoma-Reference-Cited by-同舟云学术

NQO1 induction mediated by photodynamic therapy synergizes with β-Lapachone-halogenated derivative against melanoma

Published:2018-12 Issue: Volume:108 Page:1553-1564
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Lamberti María Julia,Morales Vasconsuelo Ana Belén,Chiaramello Marianela,Ferreira Vitor Francisco,Macedo Oliveira Milena,Baptista Ferreira Sabrina,Rivarola Viviana Alicia,Rumie Vittar Natalia Belén

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference47 articles.

1. Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies;Mattia;Cell Death Dis.,2018

2. The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells;Garate;Free Radic. Biol. Med.,2010

3. The expression of NAD(P)H:quinone oxidoreductase 1 is increased along with NF-kappaB p105/p50 in human cutaneous melanomas;Cheng;Oncol. Rep.,2010

4. Patient outcome prediction using multiple biomarkers in human melanoma : A clinicopathological study of 118 cases;Li;Exp. Ther. Med.,2011

5. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity;Pink;J. Biol. Chem.,2000

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increasing the polarity of β-lapachone does not affect its binding capacity with bovine plasma protein;International Journal of Biological Macromolecules;2024-04

2. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer;International Journal of Nanomedicine;2024-03

3. The m-TORC1 inhibitor Sirolimus increases the effectiveness of Photodynamic therapy in the treatment of cutaneous Squamous Cell Carcinoma, impairing NRF2 antioxidant signaling;International Journal of Biological Sciences;2024

4. β‐lapachone protects against doxorubicin‐induced hepatotoxicity through modulation of NAD⁺/SIRT‐1/FXR/p‐AMPK/NF‐kB and Nrf2 signaling axis;Journal of Biochemical and Molecular Toxicology;2023-10-23

5. Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump;Frontiers in Cardiovascular Medicine;2023-07-18